NO972313D0 - Peptider som er i stand til å binde til GAP-protein-SH3-området, nukleotid-sekvenser som koder for dette samt fremstilling og bruk derav - Google Patents

Peptider som er i stand til å binde til GAP-protein-SH3-området, nukleotid-sekvenser som koder for dette samt fremstilling og bruk derav

Info

Publication number
NO972313D0
NO972313D0 NO972313A NO972313A NO972313D0 NO 972313 D0 NO972313 D0 NO 972313D0 NO 972313 A NO972313 A NO 972313A NO 972313 A NO972313 A NO 972313A NO 972313 D0 NO972313 D0 NO 972313D0
Authority
NO
Norway
Prior art keywords
binding
region
production
nucleotide sequences
sequences encoding
Prior art date
Application number
NO972313A
Other languages
English (en)
Other versions
NO972313L (no
Inventor
Marc Duchesne
Didier Faucher
Fabienne Parker
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9413955A external-priority patent/FR2727116B1/fr
Priority claimed from FR9505753A external-priority patent/FR2734266B1/fr
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO972313L publication Critical patent/NO972313L/no
Publication of NO972313D0 publication Critical patent/NO972313D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C07K14/4706—Guanosine triphosphatase activating protein, GAP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO972313A 1994-11-22 1997-05-21 Peptider som er i stand til å binde til GAP-protein-SH3-området, nukleotid-sekvenser som koder for dette samt fremstilling og bruk derav NO972313D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9413955A FR2727116B1 (fr) 1994-11-22 1994-11-22 Peptides capables de se lier au domaine sh3 de la proteine gap, sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation
FR9505753A FR2734266B1 (fr) 1995-05-16 1995-05-16 Peptides capables de se lier au domaine sh3 de la proteine gap sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation
PCT/FR1995/001539 WO1996016169A1 (fr) 1994-11-22 1995-11-22 Peptides capables de se lier au domaine sh3 de la proteine gap, sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation

Publications (2)

Publication Number Publication Date
NO972313L NO972313L (no) 1997-05-21
NO972313D0 true NO972313D0 (no) 1997-05-21

Family

ID=26231549

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972313A NO972313D0 (no) 1994-11-22 1997-05-21 Peptider som er i stand til å binde til GAP-protein-SH3-området, nukleotid-sekvenser som koder for dette samt fremstilling og bruk derav

Country Status (18)

Country Link
US (1) US5886150A (no)
EP (1) EP0793721B1 (no)
JP (2) JPH10509044A (no)
AT (1) ATE305037T1 (no)
AU (1) AU713937B2 (no)
BR (1) BR9510067A (no)
CA (1) CA2204438A1 (no)
CZ (1) CZ292538B6 (no)
DE (1) DE69534471T2 (no)
DK (1) DK0793721T3 (no)
ES (1) ES2248800T3 (no)
FI (1) FI972170A0 (no)
HU (1) HU221410B1 (no)
IL (1) IL116026A (no)
MX (1) MX9703364A (no)
NO (1) NO972313D0 (no)
SK (1) SK287034B6 (no)
WO (1) WO1996016169A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780062B1 (fr) * 1998-06-17 2000-07-28 Rhone Poulenc Rorer Sa Anticorps monoclonaux diriges contre la proteine g3bp, et leurs utilisations
TWI257394B (en) 1998-10-23 2006-07-01 Kirin Amgen Inc Thrombopoietic compounds
US6864355B1 (en) 2000-05-02 2005-03-08 Yale University Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
US20040022779A1 (en) * 2000-06-16 2004-02-05 Thomas Rudel Method for identifying apoptosis-modified proteins
US7846746B2 (en) * 2001-04-10 2010-12-07 Children's Medical Center Corporation Methods of analysis and labeling of protein-protein interactions
US20050069999A1 (en) * 2001-07-09 2005-03-31 Sharma Sreenath V Sh3 domain binding inhibitors
WO2003006060A1 (fr) * 2001-07-09 2003-01-23 Kyowa Hakko Kogyo Co., Ltd. Inhibiteurs de la liaison au domaine sh3
AUPR721101A0 (en) * 2001-08-23 2001-09-13 University Of Queensland, The Nucleic acid and polypeptide linked to breast cancer
WO2006010057A2 (en) * 2004-07-08 2006-01-26 Amgen Inc. Therapeutic peptides
BRPI0516011A (pt) * 2004-09-24 2008-08-19 Amgen Inc moléculas fc modificadas
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
JO3324B1 (ar) 2006-04-21 2019-03-13 Amgen Inc مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية
US11237168B2 (en) * 2019-06-26 2022-02-01 St. Jude Children's Research Hospital Method for identifying modulators of G3BP activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA894726B (en) * 1988-06-27 1990-03-28 Akzo Nv Coccidiosis vaccine
ATE181332T1 (de) * 1989-08-21 1999-07-15 Chiron Corp Vom gtpase-aktivierenden protein (gap) abgeleitete peptide sowie deren diagnostische und therapeutische verwendung
CA2057675A1 (en) * 1990-12-24 1992-06-25 Michael D. Schaber Peptide inhibitors of ras-gap interaction
FR2694296B1 (fr) * 1992-07-30 1994-09-02 Rhone Poulenc Rorer Sa Peptides inhibant l'activité des protéines ras, préparation et utilisation.
EP0679185A1 (en) * 1993-01-15 1995-11-02 Schering Corporation Ras associated gap proteins

Also Published As

Publication number Publication date
MX9703364A (es) 1997-08-30
US5886150A (en) 1999-03-23
HUT77029A (hu) 1998-03-02
CZ292538B6 (cs) 2003-10-15
FI972170A (fi) 1997-05-21
DK0793721T3 (da) 2006-01-30
EP0793721A1 (fr) 1997-09-10
IL116026A0 (en) 1996-01-31
SK287034B6 (sk) 2009-10-07
AU713937B2 (en) 1999-12-16
BR9510067A (pt) 1997-12-30
ES2248800T3 (es) 2006-03-16
FI972170A0 (fi) 1997-05-21
DE69534471T2 (de) 2006-06-22
CA2204438A1 (fr) 1996-05-30
ATE305037T1 (de) 2005-10-15
NO972313L (no) 1997-05-21
AU4263696A (en) 1996-06-17
SK62997A3 (en) 1998-02-04
EP0793721B1 (fr) 2005-09-21
JP2006122049A (ja) 2006-05-18
IL116026A (en) 2005-08-31
HU221410B1 (en) 2002-09-28
JPH10509044A (ja) 1998-09-08
CZ154597A3 (en) 1997-10-15
DE69534471D1 (de) 2006-02-02
WO1996016169A1 (fr) 1996-05-30

Similar Documents

Publication Publication Date Title
BR9910089A (pt) Composições e antìgenos de neisseria meningitidis
DK0910647T3 (da) Human DNase i hyperaktive varianter
FI961886A (fi) Ihmisen Kunitz-tyyppiset proteaasi-inhibiittorit
BR9814276A (pt) Antìgenos de superfìcie
RU95110871A (ru) Способы определения нуклеотидной последовательности
NO972313L (no) Peptider som er i stand til å binde til GAP-protein-SH3-området, nukleotid-sekvenser som koder for dette samt fremstilling og bruk derav
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
DK1025237T3 (da) Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder
FI952094A0 (fi) Ihmisen serotoniinireseptoria (5-HT4B)koodaava DNA ja sen käyttö
BR9910787A (pt) Métodos e composições úteis para modulação deangiogênese usando tirosina cinase src
SE9602822D0 (sv) New receptor
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
ATE317021T1 (de) Antisense modulierung von lfa-3
IT1275909B1 (it) Frammento di dna codificante d-amminoacido ossidasi
DE69529235T2 (de) Menschliche dnase i varianten
SE9604439D0 (sv) New receptor
BG101847A (en) Human dnase i variants

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application